Myelodysplastic Syndrome Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-na ïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndromes(MDS) Interventions: Drug: Lemzoparlimab+Azacitidine (AZA); Drug: Azacitidine (AZA) Sponsor: I-Mab Biopharma Co. Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2023 Category: Research Source Type: clinical trials
